
Innovations in Pharmaceutical Innovation A blog/ part-work from Mike Rea, exploring pharmaceutical innovation in general, and more specifically the approach to using the learning process for competitive advantage
| Platform | Pricing | Only free issues | Publishes | Twice weekly | |
|---|---|---|---|---|---|
| Issues | 337 | Founded | 6 years ago | Last Issue | 3 days ago |
| Active | |||||

A finished blockbuster earns about twelve times its best year. The tirzepatide argument is whether it gets the twelve.
Humira’s best year, in today’s money, was about $26 billion. Tirzepatide’s run-rate in the first half of 2026 is roughly...
A molecule entering Phase I today has, on the latest ten-year Citeline data, a 6.7% chance of approval. Phase II remains the wall: 28% of programmes get through it. And the Phase I transition rate, which sat above 75% in the 2006-08 cohorts...
The usual New Product Planning package is a Target Product Profile, an eNPV, and a Clinical Development Plan. Then the team runs into the same hurdles as everyone else with a similar molecule. A TPP is often not a target at all. It is a pro...
Let’s imagine, once again, that you and another team are given the same molecule.
You both have a mechanism that looks interesting, a first-in-human curve that is more suggestive than conclusive, and a patient need whose magnitude is being...
A companion to last week’s “Polate: The Missing Verb in Asymmetric Learning.” In that piece, I gave a name to the gap. This one gives the name some structure, before the products and the companies get their own post, next week.
Last week’s...
Subscribers, engagement, traffic and sponsorship for Asymmetric Learning.
| Subscribers | Engagement | 73 | Monthly Web Visits | ||
|---|---|---|---|---|---|
| Accepts Sponsors | Estimated Cost per Ad | ||||
The writers behind this newsletter.
Was CEO, IDEA Pharma. Pharmaceutical innovation geek. Senior Fellow @fastercures. Author: Pharmaceutical Positioning. My record label: Medical Records. Large, Geordie, dog fan, street-foodie
You can find recent issues that have been published by Asymmetric Learning on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.
To see how many people subscribe to Asymmetric Learning, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.
Newsletter advertising can be extremely effective when it's done right. Before you pitch Asymmetric Learning as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.
Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.
Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.
To find out how much an ad will cost, contact Asymmetric Learning using the contact information provided and ask for a copy of their media kit.
Scroll up to where it says Related Newsletters to see other publications like Asymmetric Learning. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.
Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.